References
1 Micieli R, & Alavi A. (2018). Eruptive lentiginosis in resolving
psoriatic plaques. JAAD Case Reports, 4(9),
924–929. doi:10.1016/j.jdcr.2018.07.021
2 Friedland R, David M, Feinmesser M, Barzilai A, & Hodak E. (2011).
NB-UVB (311-312 nm)-induced lentigines in patients with mycosis
fungoides: a new adverse effect of phototherapy. Journal of the European
Academy of Dermatology and Venereology, 26(9), 1158–1162.
doi:10.1111/j.1468-3083.2011.04189.x
3 Bovenschen HJ, Tjioe M, Vermaat H, Hoop D, Witteman BMJ., Janssens
RWA., … Kerkhof PCM. (2006). Induction of eruptive benign
melanocytic naevi by immune suppressive agents, including biologicals.
British Journal of Dermatology, 154(5),
880–884. doi:10.1111/j.1365-2133.2006.07189.x
4 Villalón G, Martín JM, Pinazo MI, Calduch L, Alonso V, Jordá E.
(2009). Focal Acral Hyperpigmentation in a Patient Undergoing
Chemotherapy with Capecitabine. American Journal of Clinical
Dermatology, 10(4), 261–263. doi:10.2165/00128071-200910040-00006
5 Wolf R, Orion E, & Davidovici B. (2008). Acral lentigines: a new
paraneoplastic syndrome. International Journal of Dermatology, 47(2),
168–170. doi:10.1111/j.1365-4632.2008.03223.x
6 Woodhouse J, Maytin EV. (2005). Eruptive nevi of the palms and soles.Journal of the American Academy of Dermatology, 52(5),
S96–S100. doi:10.1016/j.jaad.2004.08.009
7 Martín Hernández, JM, Donat Colomer J, Monteagudo Castro C,
Fernández-Delgado Cerdá R, Alonso Usero V, Jordá Cuevas E. (2006). Nevos
acrales eruptivos tras quimioterapia en niños afectados de leucemia
linfoblástica aguda. Anales de Pediatría, 65(3),
260–262. doi:10.1157/13092164
8 Park YJ, Soh BW, Lee ES. Acral lentiginosis associated with
tegafur/gimeracil/oteracil (TS-1). Eur J Dermatol .
2017;27(2):209-210. doi:10.1684/ejd.2016.2953
9 Reutter JC, Long EM, Morrell DS, Thomas NE, Groben PA.
(2007). Eruptive Post-Chemotherapy In Situ Melanomas and Dysplastic
Nevi. Pediatric Dermatology, 24(2),
135–137. doi:10.1111/j.1525-1470.2007.00359.x